Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.
Wasik AM, Gandy MN, McIldowie M, Holder MJ, Chamba A, Challa A, Lewis KD, Young SP, Scheel-Toellner D, Dyer MJ, Barnes NM, Piggott MJ, Gordon J. Wasik AM, et al. Among authors: mcildowie m. Invest New Drugs. 2012 Aug;30(4):1471-83. doi: 10.1007/s10637-011-9730-5. Epub 2011 Aug 18. Invest New Drugs. 2012. PMID: 21850491
A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.
Johnston TH, Millar Z, Huot P, Wagg K, Thiele S, Salomonczyk D, Yong-Kee CJ, Gandy MN, McIldowie M, Lewis KD, Gomez-Ramirez J, Lee J, Fox SH, Martin-Iverson M, Nash JE, Piggott MJ, Brotchie JM. Johnston TH, et al. Among authors: mcildowie m. FASEB J. 2012 May;26(5):2154-63. doi: 10.1096/fj.11-195016. Epub 2012 Feb 17. FASEB J. 2012. PMID: 22345403
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
Johnston TH, Fox SH, McIldowie MJ, Piggott MJ, Brotchie JM. Johnston TH, et al. Among authors: mcildowie mj. J Pharmacol Exp Ther. 2010 Jun;333(3):865-73. doi: 10.1124/jpet.110.166629. Epub 2010 Mar 15. J Pharmacol Exp Ther. 2010. PMID: 20231306
A "plug-and-play" approach to the preparation of transparent luminescent hybrid materials based on poly(methyl methacrylate), a calix[4]arene cross-linking agent, and terbium ions.
Driscoll CR, Reid BL, McIldowie MJ, Muzzioli S, Nealon GL, Skelton BW, Stagni S, Brown DH, Massi M, Ogden MI. Driscoll CR, et al. Among authors: mcildowie mj. Chem Commun (Camb). 2011 Apr 7;47(13):3876-8. doi: 10.1039/c0cc05570k. Epub 2011 Feb 18. Chem Commun (Camb). 2011. PMID: 21336345
11 results